Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first‐line tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first‐line tyrosine kinase inhibitors

Published:2022-11-30 Issue:3 Volume:30 Page:319-327
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Takemoto Kenshiro¹,Sekino Yohei¹^ORCID,Kitano Hiroyuki¹,Ikeda Kenichiro¹,Goto Keisuke¹^ORCID,Hieda Keisuke¹,Hayashi Tetsutaro¹,Hasegawa Yasuhisa²,Kato Masao³,Kadonishi Yuichi⁴,Kajiwara Mitsuru⁵,Teishima Jun¹,Mita Koji⁶,Maruyama Satoshi⁷,Shigeta Masanobu⁸,Hinata Nobuyuki¹^ORCID

Affiliation:

1. Department of Urology, Graduate School of Biomedical and Health Science Hiroshima University Hiroshima Japan

2. Department of Urology Fukuyama Medical Center Fukuyama Japan

3. Department of Urology Hiroshima General Hospital Hatsukaichi Japan

4. Department of Urology Onomichi General Hospital Onomichi Japan

5. Department of Urology Hiroshima Prefectural Hospital Hiroshima Japan

6. Department of Urology Hiroshima‐City Asa Citizens Hospital Hiroshima Japan

7. Department of Urology Miyoshi Central Hospital Miyoshi Japan

8. Department of Urology Kure Medical Center and Chugoku Cancer Center Kure Japan

Publisher

Wiley

Subject